Marta Ortega-Valle - 01 Jun 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC

Role: Chief Business Officer
Signature: /s/ David Kennedy, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Jun 2022
Net transactions value: +$6,854
Form type: 4
Filing time: 07 Sep 2022, 16:11:00 UTC
Previous filing: 08 Aug 2022
Next filing: 26 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRNA	Common Stock	Options Exercise	$6,854	+29,798		$0.2300	29,798	01 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GRNA	Stock Option (Right to Buy)	Options Exercise		-29,798	-100%		0	01 Jun 2022	Common Stock	29,798	$0.2300	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	100% of the shares subject to this option are fully vested and exercisable.
F2	This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.